| mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.35 |
4e-07 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-06 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-06 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
6e-06 |
| mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-06 |
| mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-06 |
| mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-05 |
| mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |